Stroke Prevention in Atrial Fibrillation
VideosWebinarsKey ArticlesIndependent Medical EducationNew This MonthGuidelinesRandomised Controlled TrialsMeta-AnalysesReal World studiesDabigatranRivaroxabanEdoxabanApixabanDiabetesElderlyHypertensionValvular Heart DiseaseOther studiesReviewsSpecific Clinical IndicationsPractical Aspects of UseReversal AgentsStrategies
New This Month
-
Rhanderson Cardoso, Leonardo Knijnik, Aditya Bhonsale, et alCardoso R et al. Heart Rhythm. 2017, 13 September.
-
L. Staerk, T. A. Gerds, Gregory Y. H. Lip, et alStaerk L et al. J Intern Med. 2017, 21 September.
-
Siyang Peng, Kristen A. Deger, Anastasia Ustyugova, et alPeng S et al. Curr Med Res Opin. Published online 26 September, 2017.
-
Gregory Y H Lip, Flemming Skjøth, Peter Brønnum Nielsen, et alJAMA Cardiol. Published online Jun 14, 2017.
Literature review: stroke prevention in atrial fibrillation
The review includes the pivotal randomised controlled trials for warfarin and direct oral anticoagulants as well as relevant publications from the last 18 months. The following search terms were used: ‘stroke prevention’, ‘atrial fibrillation’, dabigatran, rivaroxaban, apixaban, edoxaban, warfarin, ‘oral anticoagulants’, ‘non-VKA oral anticoagulants’, novel oral anticoagulants’, ‘direct oral anticoagulants’, ‘reversal agents’
Videos
-
06 April 2018 -
06 April 2018 -
14 February 2018 -
14 February 2018 -
14 February 2018 -
10 November 2017
Pages
Webinars
-
Dr Robert Byrne, Prof Georg Nickenig, Prof Stefan Hohnloser, Prof Georg Nickenig, Prof Pepe Zamorano, Dr Jose Lopez-Sendon. -
Gheorghe-Andrei Dan -
Dr. Amit Mistri
Key Articles
-
Joseph De Bono, Paulus Kirchhofde Bono J et al. Eur Heart J. 2018;39:1324-1325.
-
David ConenConen D. Eur Heart J. 2018;39:13230-1324.
-
Alvin Chandra, Eldrin F. Lewis, Brian L. Claggett, et alChandra A et al. JAMA Cardiol. 4 April, 2018. Epub ahead of print.
-
Alexandros Briasoulis, Chakradhari Inampudi, Emmanuel Akintoye, et alBriasoulis A et al. J Am Heart Assoc. 2018;7:e008773.
Independent Medical Education
-
Byrne R, Hohnloser S, Nickenig G, Sendon JL and Zamarano JL, Radcliffe-CME, Feb 2018. -
Harald Darius -
Torben Bjerregaard Larsen, Flemming Skjoth, Peter Bronnum Nielsen, et alBMJ 2016;353:i3189
-
Hugh Calkins, A John Camm
Guidelines/ Expert Recommendations
-
Craig T. January, Samuel Wann, Joseph S. Alpert, et alJ Am Coll Cardiol. 2014 Dec 2;64(21):e1-76.
-
Giuseppe Boriani, Hugh Calkins, Gheorghe Andrei Dan, et alEuropace (2015) 17 (8): 1197-1214.
-
Paulus Kirchhof, Dipak Kotecha, Dan Atar, et alEur Heart J (2016) 37 (38): 2893-2962.
-
Hugh Calkins, Karl-Heinz Kuck, Riccardo Cappato, et alHeart Rhythm 2012;9:632–696.e21
Randomised Controlled Trials
-
Michael D. Ezekowitz, John Eikelboom, Jonas Oldgren, et alEuropace (2016) 18 (7): 973-978
-
Stuart J. Connolly, Michael D. Ezekowitz, Salim Yusuf, et alN Engl J Med 2009;361:1139-51
-
Circulation. 1991 Aug;84(2):527-39.
-
Robert P Giugliano, Christian T. Ruff, Eugene Braunwald, et alN Engl J Med. 2013 Nov 28;369(22):2093-104.
Meta-Analyses
-
Elgendy AY, Dhruv Mahtta, Amr F. Barakat, et alElgendy AY et al. Am J Cardiol. 2017, 8 August.
-
Kinjal Banerjee, Kanhaiya Poddar, Stephanie Mick, et alBanerjee K et al. Am J Cardiol. 2017, 1 August. pii: S0002-9149(17)31232-8.
-
Andreas Clemens, Mandy Fraessdorf, Jeffrey Friedman, et alVasc Health Risk Manag 2013;9:599-615
-
N. S. Roskell, Gregory YH Lip, Heiko Noack, et alThromb Haemost 2010;104:1106-15
Real World / Retrospective Studies
-
Marco Proietti, Cécile Laroche, Ole Nyvad, et alProietti M et al. Int J Cardiol. 2017;248:166-172.
-
Adrienne M. Gilligan, Pranav Gandhi, Xue Song, et alGilligan AM et al. Am J Cardiovasc Drugs. Published online 9 August, 2017.
-
Miney Paquette, Lionel Riou França, Christine Teutsch, et alPaquette M et al. J Am Coll Cardiol. 2017;70:1573-1583.
-
Menno V. Huisman, Kenneth J. Rothman, Miney Paquette, et alHuisman et al. Am Heart J. 2017.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Dabigatran
-
Michael D. Ezekowitz, Lars Wallentin, Stuart J. Connolly, et alCirculation. 2010 Nov 30;122(22):2246-53.
-
Ziyad M Hijazi, Stefan H Hohnloser, Jonas Oldgren, et alCirculation. 2014;129:961-970.
-
Cost-Effectiveness of Dabigatran Compared With Warfarin for Stroke Prevention in Atrial FibrillationJames V. Freeman, Ruo P. Zhu, Douglas K. Owens, et alAnn Intern Med 2011;154:1-11
-
Analysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY TrialPeter Bytzer, Stuart J. Connolly, Sean Yang, et alGastroenterol Hepatol. 2013;11:246-252
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Rivaroxaban
-
Matthew W. Sherwood, Christopher C. Nessel, Anne S. Hellkamp, et alJ Am Coll Cardiol. 2015 Dec 1;66(21):2271-81.
-
Sean D. Pokorney, Jonathan P. Piccini, Susanna R. Stevens, et alJ Am Heart Assoc. 2016 Mar 8;5(3):e002197.
-
Christopher B. Fordyce, Anne S. Hellkamp, Yuliya Lokhnygina, et alCirculation. 2016 Jul 5;134(1):37-47.
-
Matthew W. Sherwood, Derek D. Cyr, W. Schuyler Jones, et alJACC Cardiovasc Interv. 2016 Aug 22;9(16):1694-702.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Edoxaban
-
J. Steffel, Robert P Giugliano, Eugene Braunwald, et alEur Heart J. 2015 Sep 1;36(33):2239-45.
-
Erin A. Bohula, Robert P Giugliano, Christian T. Ruff, et alCirculation. 2016 Jul 5;134(1):24-36.
-
Robert P Giugliano, Christian T. Ruff, Stephen D. Wiviott, et alAm J Med. 2016 Aug;129(8):850-857.e2.
-
Natalia S. Rost, Robert P Giugliano, Christian T. Ruff, et alStroke. 2016 Aug;47(8):2075-82.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Apixaban
-
Dragos Vinereanu, Susanna R. Stevens, John H. Alexander, et alEur Heart J. 2015 Dec 7;36(46):3268-75.
-
Ziyad M Hijazi, Stefan H Hohnloser, U. Andersson, et alJAMA Cardiol. 2016 Jul 1;1(4):451-60.
-
Patrícia O. Guimarães, Daniel M. Wojdyla, John H. Alexander, et alInt J Cardiol. 2017 Jan 15;227:443-449.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Diabetes
-
Harald Darius, Jonas Oldgren, Andreas Clemens, et alInt J Cardiol. 2015 Oct 1;196:127-31.
-
Sameer Bansilal, Zachary Bloomgarden, Jonathan L. Halperin, et alAm Heart J. 2015 Oct;170(4):675-682.e8.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Elderly
-
Giulia Magnani, Robert P Giugliano, Christian T. Ruff, et alEur J Heart Fail. 2016 Sep;18(9):1153-61.
-
Eri Toda Kato, Robert P Giugliano, Christian T. Ruff, et alJ Am Heart Assoc, 2016;5:. pii: e003432.
-
Olivier Hanon, Jean-Yves Le Heuzey, Paulus Kirchhof, et alInt J Cardiol, 2017;232:98-104.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Hypertension
-
Meena P. Rao, Sigrun Halvorsen, Daniel M. Wojdyla, et alJ Am Heart Assoc. 2015 Dec 1;4(12). pii: e002015.
-
Sreekanth Vemulapalli, Anne S. Hellkamp, W. Schuyler Jones, et alAm Heart J. 2016 Aug;178:74-84.
-
Claudio Borghi, Stefania Paolillo, Arrigo FG Cicero, et alJ Hypertens. 2017 Apr;35(4):689-695.
Post-Hoc/Subgroup Analysis Of Pivotal Trials - Valvular
-
Michael D. Ezekowitz, Rangadham Nagarakanti, Herbert Noack, et alCirculation. 2016 Aug 23;134(8):589-98.
Other Studies
-
Jeffrey Friedman, Andreas Clemens, D. Khadzhynov, et alThromb Haemost. 2013;109:596-605.
-
Stefan H Hohnloser, A John CammEuropace. 2013;15:1407-1411
-
Stuart J. Connolly, Lars Wallentin, Michael D. Ezekowitz, et alCirculation. 2013;128:A10684
-
Andreas Clemens, J. van Ryn, S. Härtter, et alThromb Haemost. 2010;103:1116-1127.
Reviews/Others
-
Darryl P. Leong, Philip G. Joseph, Martin McKee, et alLeong DP et al. Circ Res. 2017;121:695-710.
-
A. J. A. McLellan, Markus P SchlaichThromb Haemost 2013;109:580-1
-
Graeme J. Hankey, J. W. EikelboomCirculation 2011;123:1436-50
-
Gerald V Naccarelli, Mark J. Alberts, Richard A. Bernstein, et alStroke 2012;43:271-9
Specific Clinical Indications
-
C Fielder Camm, A John CammCamm CF et al. Arrhythm Electrophysiol Rev. 2017;6:53-68.
Practical Aspects of Use
-
Thomas F LüscherLüscher TF et al. Eur Heart J. 2017;38:2573-2575.
-
Eunice Yang, Esra Gucuk Ipek, Muhammad Balouch, et alYang E et al. Europace. 2017;19:241-249.
-
Andreas Goette, Hein HeidbuchelGoette A et al. Arrhythm Electrophysiol Rev. 2017;6:50-54.
-
Brystana G Kaufman, Sunghee Kim, Karen S. Pieper, et alKaufman BG et al. Heart. 2017, 8 Aug. pii: heartjnl-2017-311800.
Reversal Agents
-
António Tralhão, Carlos Aguiar, Jorge Ferreira, et alTralhão A et al. Thromb J. 2017;15:23.
Ablation strategies
-
Hugh Calkins, Gerhard Hindricks, Riccardo Cappato, et alCalkins H et al. Europace. 2017;0:1-52.
-
Naga Venkata Pothineni, Srikanth VallurupalliUS Cardiology Review 2018;12(2):ePub: 14 March 2018.DOI: https://doi.org/10.15420/usc.2017:39:1
-
Manav SohalEuropean Cardiology Review 2017;12(1):38–9.DOI: https://doi.org/10.15420/ecr.2017:10:2
-
Piotr PonikowskiEuropean Cardiology Review,2012 ; (3):150
-
Gerhard HindricksEuropean Cardiology Review,2012 ; (3):174 - 8DOI: http://dx.doi.org/10.15420/ecr.2012.8.3.174
